— Cutting-edge prostate cancer projects range from AI-powered diagnosis and risk prediction to targeted therapies that overcome treatment resistance — The Prostate Cancer Foundation (PCF) today ...
Rising ovarian and uterine cancer rates are linked to high BMI, with disparities across sociodemographic index levels, particularly in low- and middle-SDI regions. Sarcopenia is prevalent in ...
Surgery and chemotherapy together improved survival in GIST patients with liver metastases, increasing median cancer-specific and overall survival significantly. Chemoradiation did not enhance relapse ...
Researchers demonstrate breakthroughs in cancer treatment quality through AI-enhanced data analytics
Cancer researchers at the University of Tennessee Health Science Center have published three new studies demonstrating how advanced artificial intelligence and population health analytics can identify ...
Atezolizumab, combined with chemotherapy, did not improve survival in high-risk triple-negative breast cancer and had higher severe adverse events. A Swedish study found 30% of breast cancers were ...
Abenacianine, a fluorescent imaging agent, received FDA fast track status for enhancing tumor visualization during lung cancer surgery, showing safety and efficacy in phase 2 trials. Alecensa ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results